A detailed history of Capitolis Liquid Global Markets LLC transactions in Dexcom Inc stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 175,000 shares of DXCM stock, worth $15.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
175,000
Holding current value
$15.9 Million
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $11.5 Million - $14.2 Million
175,000 New
175,000 $13.6 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $35.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Capitolis Liquid Global Markets LLC Portfolio

Follow Capitolis Liquid Global Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Liquid Global Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Liquid Global Markets LLC with notifications on news.